首页 > 最新文献

International Journal of Pharmaceutics最新文献

英文 中文
Characterization of anatomical variations of the nasal cavity in a subset of European patients and their impact on intranasal drug delivery 欧洲部分患者鼻腔解剖变异的特征及其对鼻内给药的影响。
IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-26 DOI: 10.1016/j.ijpharm.2024.124851
Mike Pasteur , Guillaume Arsouze , Guy Ilango , Déborah Le Pennec , Dimitri Kulker , Anaïs Heyraud , Jean-Philippe Cottier , Charles Aussedat , Nathalie Heuzé-Vourc’h , Virginie Hervé , Sandrine Le Guellec
Anatomical 3D-printed nasal casts are valuable models to investigate intranasal drug deposition, providing preclinical data that cannot be obtained in animal models. However, these models are limited since they are often derived from a single patient or represent a mean of several groups. The present study aimed to better characterize the anatomical differences of the nasal cavity in a European sub-population and to assess the potential impact of anatomical variations on intranasal deposition by medical devices. Ninety-eight cranial computed tomography scans of patients were selected and analyzed in 2D and 3D conformations. They showed symmetry of cavities and a high level of heterogeneity of measurements, especially volume and area, in the population. Three anatomical groups with distinct nasal geometry were identified and 3D nasal casts of the most representative patient of each group were printed. Fluorescein was administered using three medical devices: a nasal spray, a sonic jet nebulizer and a prototype mesh-nebulizer. The deposition profiles were compared with the Aeronose® as a reference. Our results show that anatomical variations influenced the deposition profiles depending on the device, with a higher variation with spray and the mesh-nebulizer. This work emphasises the importance of anatomical parameters on drug intranasal deposition and the need to evaluate inhaled drugs on different 3D nasal casts reflecting the target population.
解剖三维打印鼻腔模型是研究鼻内药物沉积的宝贵模型,可提供动物模型无法获得的临床前数据。然而,这些模型往往来自单一患者或代表几组患者的平均值,因此存在局限性。本研究旨在更好地描述欧洲亚人群鼻腔的解剖学差异,并评估解剖学差异对医疗器械鼻内沉积的潜在影响。研究人员选取了 98 名患者的头颅计算机断层扫描图像,并对其进行了二维和三维构型分析。扫描结果显示,患者的鼻腔具有对称性,测量结果(尤其是体积和面积)具有高度异质性。确定了具有不同鼻腔几何形状的三个解剖学组别,并为每个组别中最具代表性的患者打印了三维鼻腔模型。使用三种医疗设备施用荧光素:鼻腔喷雾器、声波喷射雾化器和原型网状雾化器。以 Aeronose® 为参照,对沉积曲线进行了比较。我们的研究结果表明,解剖结构的变化对沉积曲线的影响取决于不同的设备,喷雾器和网状雾化器的沉积曲线变化较大。这项工作强调了解剖参数对药物鼻内沉积的重要性,以及在反映目标人群的不同 3D 鼻腔模型上评估吸入药物的必要性。
{"title":"Characterization of anatomical variations of the nasal cavity in a subset of European patients and their impact on intranasal drug delivery","authors":"Mike Pasteur ,&nbsp;Guillaume Arsouze ,&nbsp;Guy Ilango ,&nbsp;Déborah Le Pennec ,&nbsp;Dimitri Kulker ,&nbsp;Anaïs Heyraud ,&nbsp;Jean-Philippe Cottier ,&nbsp;Charles Aussedat ,&nbsp;Nathalie Heuzé-Vourc’h ,&nbsp;Virginie Hervé ,&nbsp;Sandrine Le Guellec","doi":"10.1016/j.ijpharm.2024.124851","DOIUrl":"10.1016/j.ijpharm.2024.124851","url":null,"abstract":"<div><div>Anatomical 3D-printed nasal casts are valuable models to investigate intranasal drug deposition, providing preclinical data that cannot be obtained in animal models. However, these models are limited since they are often derived from a single patient or represent a mean of several groups. The present study aimed to better characterize the anatomical differences of the nasal cavity in a European sub-population and to assess the potential impact of anatomical variations on intranasal deposition by medical devices. Ninety-eight cranial computed tomography scans of patients were selected and analyzed in 2D and 3D conformations. They showed symmetry of cavities and a high level of heterogeneity of measurements, especially volume and area, in the population. Three anatomical groups with distinct nasal geometry were identified and 3D nasal casts of the most representative patient of each group were printed. Fluorescein was administered using three medical devices: a nasal spray, a sonic jet nebulizer and a prototype mesh-nebulizer. The deposition profiles were compared with the Aeronose® as a reference. Our results show that anatomical variations influenced the deposition profiles depending on the device, with a higher variation with spray and the mesh-nebulizer. This work emphasises the importance of anatomical parameters on drug intranasal deposition and the need to evaluate inhaled drugs on different 3D nasal casts reflecting the target population.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"667 ","pages":"Article 124851"},"PeriodicalIF":5.3,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RF pulsed plasma modified composite scaffold for enhanced anti-microbial activity and accelerated wound healing 射频脉冲等离子体改性复合支架用于增强抗微生物活性和加速伤口愈合。
IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-24 DOI: 10.1016/j.ijpharm.2024.124864
A.M. Trimukhe , J.S. Melo , D. Chaturvedi , R.D. Jain , P. Dandekar , R.R. Deshmukh
Infected wounds present significant challenges pertaining to healing and often demand administration of strong antibiotics to patients. Also, drug resistant microbes may alter the physiology of wounds to create biofilms, frequently leading to high morbidity and mortality. In this investigation, a biodegradable, microporous composite agarose-chitosan scaffold was fabricated. Furthermore, its surface was modified with diphenyldiselenide deposition, using low pressure pulsed plasma technology. The optimized plasma parameters, viz. 5ON/15OFF (ms) of plasma pulse rate and 80 min of treatment time resulted in scaffolds having enhanced anti-bacterial activity against gram positive microbes like Staphylococcus (S.) aureus and S. epidermidis. The scaffolds were non-toxic to skin cells, as confirmed by the MTT assay. Cell proliferation through plasma treated and untreated scaffolds was assessed by culturing primary human dermal fibroblasts (HdaF) and human keratinocytes (HaCaT) and visualizing via confocal microscopy. Moreover, in-vivo rat model confirmed accelerated wound healing with plasma treated scaffold (100 % on day 14), as compared to the untreated scaffold (100 % on day 16) when compared with over-the-counter (OTC) ointment Betadine (100 % on day 12).
受感染的伤口给愈合带来了巨大挑战,患者往往需要使用强效抗生素。此外,耐药微生物可能会改变伤口的生理结构,形成生物膜,经常导致高发病率和高死亡率。在这项研究中,我们制作了一种可生物降解的微孔复合琼脂糖-壳聚糖支架。此外,还利用低压脉冲等离子体技术对其表面进行了二苯基二硒化沉积修饰。优化的等离子体参数,即 5ON/15OFF (ms) 的等离子体脉冲速率和 80 分钟的处理时间,使支架对金黄色葡萄球菌和表皮葡萄球菌等革兰氏阳性微生物具有更强的抗菌活性。MTT 试验证实,这种支架对皮肤细胞无毒。通过培养原代人类真皮成纤维细胞(HdaF)和人类角质细胞(HaCaT),并通过共聚焦显微镜观察,评估了经血浆处理和原生支架的细胞增殖情况。此外,体内大鼠模型证实,与原生支架(第 16 天 100%)相比,经血浆处理的支架(第 14 天 100%)与非处方药(OTC)软膏倍他丁(第 12 天 100%)相比,加速了伤口愈合。
{"title":"RF pulsed plasma modified composite scaffold for enhanced anti-microbial activity and accelerated wound healing","authors":"A.M. Trimukhe ,&nbsp;J.S. Melo ,&nbsp;D. Chaturvedi ,&nbsp;R.D. Jain ,&nbsp;P. Dandekar ,&nbsp;R.R. Deshmukh","doi":"10.1016/j.ijpharm.2024.124864","DOIUrl":"10.1016/j.ijpharm.2024.124864","url":null,"abstract":"<div><div>Infected wounds present significant challenges pertaining to healing and often demand administration of strong antibiotics to patients. Also, drug resistant microbes may alter the physiology of wounds to create biofilms, frequently leading to high morbidity and mortality. In this investigation, a biodegradable, microporous composite agarose-chitosan scaffold was fabricated. Furthermore, its surface was modified with diphenyldiselenide deposition, using low pressure pulsed plasma technology. The optimized plasma parameters, viz. 5<sub>ON</sub>/15<sub>OFF</sub> (ms) of plasma pulse rate and 80 min of treatment time resulted in scaffolds having enhanced anti-bacterial activity against gram positive microbes like <em>Staphylococcus (S.) aureus</em> and <em>S. epidermidis</em>. The scaffolds were non-toxic to skin cells, as confirmed by the MTT assay. Cell proliferation through plasma treated and untreated scaffolds was assessed by culturing primary human dermal fibroblasts (HdaF) and human keratinocytes (HaCaT) and visualizing via confocal microscopy. Moreover, <em>in-vivo</em> rat model confirmed accelerated wound healing with plasma treated scaffold (100 % on day 14), as compared to the untreated scaffold (100 % on day 16) when compared with over-the-counter (OTC) ointment Betadine (100 % on day 12).</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"667 ","pages":"Article 124864"},"PeriodicalIF":5.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of conformational landscape on the polymorphism and monomorphism of tizanidine cocrystallization outcomes 构象格局对替扎尼定共晶结果的多态性和单态性的影响。
IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-24 DOI: 10.1016/j.ijpharm.2024.124859
Di Wu , Lin Fu , Hongxun Hao , Chen Chen , Gang Chen , Shuyu Li , Liu Baiqi , Ting Wang , Na Wang , Xin Huang
Molecular conformational diversity plays a crucial role in both polymorphic nucleation and cocrystal formation during the cocrystallization process. However, the relationship between molecular conformation and cocrystallization polymorphism is not well-explored. Herein, the impact of molecular conformational landscapes on cocrystallization outcomes was investigated using tizanidine (TZND) as model compound. Four coformers, namely maleic acid (MA), salicylic acid (SA), p-hydroxybenzoic acid (pHBA), and heptanedioic acid (HDA), were employed and five salt forms were developed for the first time. Compared with TZND, all five salts showed significantly improved water solubility and dissolution rate. The cocrystallization behavior of TZND varied with each coformer: MA exhibited solvent-dependent polymorphism, while SA, pHBA, and HDA showed solvent-independent monomorphism. Crystal structure and conformational analyses revealed the conformational variation of TZND across different cocrystallization outcomes. Molecular dynamics simulations and quantum chemical calculations demonstrated that the interplay between solvent effects and coformer interactions determines the dominant conformations of TZND. The cocrystallization nucleation process was also examined, and the molecular mechanism that explains both polymorphism and monomorphism in the cocrystallization of TZND was proposed.
分子构象多样性在共晶体形成过程中的多态成核和共晶体形成中起着至关重要的作用。然而,分子构象与结晶多态性之间的关系还没有得到很好的探讨。本文以替扎尼定(TZND)为模型化合物,研究了分子构象景观对结晶结果的影响。研究采用了马来酸(MA)、水杨酸(SA)、对羟基苯甲酸(pHBA)和庚二酸(HDA)四种共聚物,并首次开发了五种盐型。与 TZND 相比,这五种盐的水溶性和溶解速率都有明显提高。TZND 的共晶行为随每种共聚物的不同而变化:MA 表现出溶剂依赖性多态性,而 SA、pHBA 和 HDA 则表现出溶剂非依赖性单态性。晶体结构和构象分析揭示了 TZND 在不同共结晶结果下的构象变化。分子动力学模拟和量子化学计算表明,溶剂效应和共形作用之间的相互作用决定了 TZND 的主要构象。此外,还研究了共晶成核过程,并提出了解释 TZND 共晶过程中多态性和单态性的分子机制。
{"title":"Effect of conformational landscape on the polymorphism and monomorphism of tizanidine cocrystallization outcomes","authors":"Di Wu ,&nbsp;Lin Fu ,&nbsp;Hongxun Hao ,&nbsp;Chen Chen ,&nbsp;Gang Chen ,&nbsp;Shuyu Li ,&nbsp;Liu Baiqi ,&nbsp;Ting Wang ,&nbsp;Na Wang ,&nbsp;Xin Huang","doi":"10.1016/j.ijpharm.2024.124859","DOIUrl":"10.1016/j.ijpharm.2024.124859","url":null,"abstract":"<div><div>Molecular conformational diversity plays a crucial role in both polymorphic nucleation and cocrystal formation during the cocrystallization process. However, the relationship between molecular conformation and cocrystallization polymorphism is not well-explored. Herein, the impact of molecular conformational landscapes on cocrystallization outcomes was investigated using tizanidine (TZND) as model compound. Four coformers, namely maleic acid (MA), salicylic acid (SA), p-hydroxybenzoic acid (pHBA), and heptanedioic acid (HDA), were employed and five salt forms were developed for the first time. Compared with TZND, all five salts showed significantly improved water solubility and dissolution rate. The cocrystallization behavior of TZND varied with each coformer: MA exhibited solvent-dependent polymorphism, while SA, pHBA, and HDA showed solvent-independent monomorphism. Crystal structure and conformational analyses revealed the conformational variation of TZND across different cocrystallization outcomes. Molecular dynamics simulations and quantum chemical calculations demonstrated that the interplay between solvent effects and coformer interactions determines the dominant conformations of TZND. The cocrystallization nucleation process was also examined, and the molecular mechanism that explains both polymorphism and monomorphism in the cocrystallization of TZND was proposed.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"667 ","pages":"Article 124859"},"PeriodicalIF":5.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CaCO3-complexed pH-responsive nanoparticles encapsulating mitoxantrone and celastrol enhance tumor chemoimmunotherapy 包裹米托蒽醌和塞拉司琼的CaCO3络合pH响应纳米颗粒可增强肿瘤化疗免疫疗法。
IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-24 DOI: 10.1016/j.ijpharm.2024.124860
Liang Zhang , Huiqiang Hu , Wan Cai , Shungen Chen , Ping Sheng , Xiaomei Fu
Modulating the immunosuppressive tumor microenvironment (TME) while enhancing antitumor immune responses is a promising strategy. In this study, we designed an acid-sensitive nanosystem (MCCaNPs) to demonstrate effective immunotherapy against cancer through the systemic delivery of immune-stimulating chemotherapy combinations. A pH-responsive nanoplatform containing CaCO3 was prepared by the double emulsion method, and mitoxantrone (MIT) and celastrol (CEL) were simultaneously encapsulated as immunogenic cell death (ICD) inducers. Due to the acid responsiveness of CaCO3, the nanoparticles rapidly consume H+ to relieve the acidic tumor microenvironment and explosively release CEL and MIT, showing inherent immunomodulatory activity in collaborative tumor chemoimmunotherapy. MIT and CEL synergistically trigger stronger ICD by inducing tumor cells to release calreticulin (CRT), high mobility group box 1 protein (HMGB1). Following the intravenous administration of MCCaNPs, the local tumor microenvironment(TME) was reprogrammed in mice-bearing tumors. This reprogramming was characterized by a significant increase in the density of tumor-infiltrating cytotoxic T lymphocytes(CTLs), ultimately prolonging survival. Therefore, this research proposes a promising approach to trigger immunogenic cell death collaboratively, aiming to boost the tumor CTLs infiltration for anticancer immunotherapy.
在增强抗肿瘤免疫反应的同时调节免疫抑制性肿瘤微环境(TME)是一种前景广阔的策略。在这项研究中,我们设计了一种对酸敏感的纳米系统(MCCaNPs),通过全身性递送免疫刺激化疗组合物来展示有效的抗癌免疫疗法。我们采用双乳液法制备了含有 CaCO3 的 pH 响应纳米平台,并同时封装了米托蒽醌(MIT)和西拉斯特醇(CEL)作为免疫细胞死亡(ICD)诱导剂。由于 CaCO3 的酸响应性,纳米颗粒迅速消耗 H+ 以缓解酸性肿瘤微环境,并爆炸性地释放 CEL 和 MIT,在协同肿瘤化学免疫疗法中显示出固有的免疫调节活性。MIT 和 CEL 通过诱导肿瘤细胞释放钙粘蛋白(CRT)、高迁移率组盒 1 蛋白(HMGB1),协同触发更强的 ICD。静脉注射MCCaNPs后,小鼠肿瘤的局部肿瘤微环境(TME)发生了重编程。这种重编程的特点是肿瘤浸润细胞毒性T淋巴细胞(CTL)的密度显著增加,最终延长了生存期。因此,这项研究提出了一种很有前景的方法,即协同触发免疫原性细胞死亡,以提高肿瘤细胞毒性T淋巴细胞的浸润,从而达到抗癌免疫疗法的目的。
{"title":"CaCO3-complexed pH-responsive nanoparticles encapsulating mitoxantrone and celastrol enhance tumor chemoimmunotherapy","authors":"Liang Zhang ,&nbsp;Huiqiang Hu ,&nbsp;Wan Cai ,&nbsp;Shungen Chen ,&nbsp;Ping Sheng ,&nbsp;Xiaomei Fu","doi":"10.1016/j.ijpharm.2024.124860","DOIUrl":"10.1016/j.ijpharm.2024.124860","url":null,"abstract":"<div><div>Modulating the immunosuppressive tumor microenvironment (TME) while enhancing antitumor immune responses is a promising strategy. In this study, we designed an acid-sensitive nanosystem (MCCaNPs) to demonstrate effective immunotherapy against cancer through the systemic delivery of immune-stimulating chemotherapy combinations. A pH-responsive nanoplatform containing CaCO<sub>3</sub> was prepared by the double emulsion method, and mitoxantrone (MIT) and celastrol (CEL) were simultaneously encapsulated as immunogenic cell death (ICD) inducers. Due to the acid responsiveness of CaCO<sub>3</sub>, the nanoparticles rapidly consume H<sup>+</sup> to relieve the acidic tumor microenvironment and explosively release CEL and MIT, showing inherent immunomodulatory activity in collaborative tumor chemoimmunotherapy. MIT and CEL synergistically trigger stronger ICD by inducing tumor cells to release calreticulin (CRT), high mobility group box 1 protein (HMGB1). Following the intravenous administration of MCCaNPs, the local tumor microenvironment(TME) was reprogrammed in mice-bearing tumors. This reprogramming was characterized by a significant increase in the density of tumor-infiltrating cytotoxic T lymphocytes(CTLs), ultimately prolonging survival. Therefore, this research proposes a promising approach to trigger immunogenic cell death collaboratively, aiming to boost the tumor CTLs infiltration for anticancer immunotherapy.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"667 ","pages":"Article 124860"},"PeriodicalIF":5.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple tail ionizable lipids improve in vivo mRNA delivery efficiency with biosafety 多尾可电离脂质在生物安全的前提下提高体内 mRNA 递送效率。
IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-24 DOI: 10.1016/j.ijpharm.2024.124868
Chao Liu, Yuhao Jiang, Wenliang Xue, Jinyu Liu, Zihao Wang, Xinsong Li
Ionizable lipid-based lipid nanoparticles (LNP) play a crucial role in the delivery of mRNA. The hydrophobic tail of ionizable lipid affects the formation of LNP and the release of mRNA. In this report, we focus on the effect of the number, chain length, and double bond number of the hydrophobic tail on the delivery efficiency. First, a series of ionizable lipids with two, three and four tails were synthesized and characterized featured with imidazole group as the head. The ionizable lipids derived LNP were prepared using a microfluidic co-mixing device, yielding particles primarily in the size range of 100 to 150 nm, with a polydispersity index (PDI) below 0.2. Screening identified ionizable lipids with four tails exhibiting superior delivery efficiency, of which U-15, U-17, U-18 and U-19 demonstrated the highest performance. Additionally, the U-19 significantly prolongs mRNA expression duration, and along with specific extrahepatic delivery effect compared to ALC-0315. Tissue slice tests on representatives (U-06: two tails, U-19: four tails, U-29: three tails) revealed no notable abnormalities. Analysis of immunogenicity, liver and kidney function tests indicated that all samples exhibited no evident immunogenicity or in vivo toxicity. Findings from tests on lysosome escape, cell transfection, and cytotoxicity revealed excellent in vitro delivery effectiveness. In summary, among the 35 imidazole-based ionizable lipids screened, optimal effects were exhibited by four tails, which providing a new strategy for the development of ionizable lipids.
以可电离脂质为基础的脂质纳米颗粒(LNP)在传递 mRNA 方面发挥着至关重要的作用。可电离脂质的疏水尾部会影响 LNP 的形成和 mRNA 的释放。在本报告中,我们重点研究了疏水尾的数量、链长和双键数对递送效率的影响。首先,以咪唑基团为头,合成了一系列具有两个、三个和四个尾部的可电离脂质,并对其进行了表征。利用微流体共混装置制备了由可电离脂质衍生的 LNP,得到的颗粒尺寸主要在 100 至 150 nm 之间,多分散指数(PDI)低于 0.2。筛选确定了具有四种尾部的可电离脂质,它们具有卓越的递送效率,其中 U-15、U-17、U-18 和 U-19 的性能最高。此外,与 ALC-0315 相比,U-19 能明显延长 mRNA 的表达时间,并具有特定的肝外递送效果。对代表药物(U-06:2 尾、U-19:4 尾、U-29:3 尾)进行的组织切片测试未发现明显异常。对免疫原性、肝功能和肾功能测试的分析表明,所有样品均未表现出明显的免疫原性或体内毒性。溶酶体逸出、细胞转染和细胞毒性测试结果表明,体外递送效果极佳。总之,在筛选出的 35 种咪唑类可离子化脂质中,有四种尾部表现出最佳效果,为可离子化脂质的开发提供了一种新策略。
{"title":"Multiple tail ionizable lipids improve in vivo mRNA delivery efficiency with biosafety","authors":"Chao Liu,&nbsp;Yuhao Jiang,&nbsp;Wenliang Xue,&nbsp;Jinyu Liu,&nbsp;Zihao Wang,&nbsp;Xinsong Li","doi":"10.1016/j.ijpharm.2024.124868","DOIUrl":"10.1016/j.ijpharm.2024.124868","url":null,"abstract":"<div><div>Ionizable lipid-based lipid nanoparticles (LNP) play a crucial role in the delivery of mRNA. The hydrophobic tail of ionizable lipid affects the formation of LNP and the release of mRNA. In this report, we focus on the effect of the number, chain length, and double bond number of the hydrophobic tail on the delivery efficiency. First, a series of ionizable lipids with two, three and four tails were synthesized and characterized featured with imidazole group as the head. The ionizable lipids derived LNP were prepared using a microfluidic co-mixing device, yielding particles primarily in the size range of 100 to 150 nm, with a polydispersity index (PDI) below 0.2. Screening identified ionizable lipids with four tails exhibiting superior delivery efficiency, of which U-15, U-17, U-18 and U-19 demonstrated the highest performance. Additionally, the U-19 significantly prolongs mRNA expression duration, and along with specific extrahepatic delivery effect compared to ALC-0315. Tissue slice tests on representatives (U-06: two tails, U-19: four tails, U-29: three tails) revealed no notable abnormalities. Analysis of immunogenicity, liver and kidney function tests indicated that all samples exhibited no evident immunogenicity or <em>in vivo</em> toxicity. Findings from tests on lysosome escape, cell transfection, and cytotoxicity revealed excellent <em>in vitro</em> delivery effectiveness. In summary, among the 35 imidazole-based ionizable lipids screened, optimal effects were exhibited by four tails, which providing a new strategy for the development of ionizable lipids.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"667 ","pages":"Article 124868"},"PeriodicalIF":5.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in conjugate drug delivery System: Opportunities and challenges 共轭给药系统的进展:机遇与挑战。
IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-24 DOI: 10.1016/j.ijpharm.2024.124867
Yi-Shen Zhu , Jiaqi Wu , Feng Zhi
Ideal drug delivery system is designed to accurately deliver the drug to its intended site. The development of conjugate drug delivery system introduces a novel pathway to precise drug delivery with advantages over traditional methods. The core of a conjugate drug delivery system comprises a molecule with two functional components, bounded by a linker structure. One component is responsible for delivering or stabilizing the conjugate, while the other is used to provide the therapeutic or diagnostic effects of the bioactivity. Conjugate drug delivery system improves patient health by maintaining the structural stability of drugs in molecular form, delivering therapeutics or diagnostic material to the target site, minimising off-target accumulation and promoting patient compliance. This system includes various types of drug conjugates that modulate drug pharmacokinetics, stability, absorption, and exposure in lesions and healthy tissues. In this review, we focus on the key characteristics and recent advances of various conjugate drug delivery systems and explore their mechanisms. We also point out the current challenges faced by conjugate drug delivery system and look forward to the future prospects.
理想的给药系统旨在将药物准确地输送到预定部位。与传统方法相比,共轭给药系统的开发为精确给药提供了一条新途径。共轭给药系统的核心由一个分子和两个功能成分组成,并以连接体结构为界。其中一种成分负责递送或稳定共轭物,另一种成分用于提供生物活性的治疗或诊断效果。共轭给药系统通过保持分子形式药物的结构稳定性、将治疗或诊断材料输送到目标部位、最大限度地减少脱靶蓄积和促进患者依从性,从而改善患者的健康状况。该系统包括各种类型的药物共轭物,可调节药物在病变和健康组织中的药代动力学、稳定性、吸收和暴露。在本综述中,我们将重点介绍各种共轭给药系统的主要特点和最新进展,并探讨其作用机制。我们还指出了共轭给药系统目前面临的挑战,并展望了未来的前景。
{"title":"Advances in conjugate drug delivery System: Opportunities and challenges","authors":"Yi-Shen Zhu ,&nbsp;Jiaqi Wu ,&nbsp;Feng Zhi","doi":"10.1016/j.ijpharm.2024.124867","DOIUrl":"10.1016/j.ijpharm.2024.124867","url":null,"abstract":"<div><div>Ideal drug delivery system is designed to accurately deliver the drug to its intended site. The development of conjugate drug delivery system introduces a novel pathway to precise drug delivery with advantages over traditional methods. The core of a conjugate drug delivery system comprises a molecule with two functional components, bounded by a linker structure. One component is responsible for delivering or stabilizing the conjugate, while the other is used to provide the therapeutic or diagnostic effects of the bioactivity. Conjugate drug delivery system improves patient health by maintaining the structural stability of drugs in molecular form, delivering therapeutics or diagnostic material to the target site, minimising off-target accumulation and promoting patient compliance. This system includes various types of drug conjugates that modulate drug pharmacokinetics, stability, absorption, and exposure in lesions and healthy tissues. In this review, we focus on the key characteristics and recent advances of various conjugate drug delivery systems and explore their mechanisms. We also point out the current challenges faced by conjugate drug delivery system and look forward to the future prospects.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"667 ","pages":"Article 124867"},"PeriodicalIF":5.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanostructured lipid carriers decorated with polyphosphate coated linear and loop cell-penetrating peptides 用聚磷酸酯线性和环形细胞穿透肽装饰的纳米结构脂质载体。
IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-24 DOI: 10.1016/j.ijpharm.2024.124844
Ahmad Saleh , Daniel Stengel , Martyna Truszkowska , Mariana Blanco Massani , Gergely Kali , Andreas Bernkop-Schnürch

Aim

This study aimed to evaluate the cellular uptake of nanostructured lipid carriers (NLCs) decorated with polyphosphate coated linear and loop cell-penetrating peptides (CPPs).

Methods

Linear-CPPs and loop-CPPs were synthesized via ring-opening polymerization and anchored on the surface NLCs, followed by coating with polyphosphate (PP). These nanocarriers (NCs) were characterized in terms of particle size, polydispersity index (PDI), and zeta potential. Cell viability and hemolysis, as well as enzyme-induced charge conversion via phosphate cleavage by free and membrane-bound intestinal alkaline phosphatase (IAP) were investigated. Cellular uptake studies by Caco-2 and HEK cells were quantitatively analyzed by flow cytometry and visualized by confocal microscopy.

Results

A shift in charge from positive to negative was obtained for both linear- and loop-CPPs-NLCs by coating with PP. PP-linear-CPPs-NLCs and PP-loop-CPPs-NLCs exhibited a particle size < 270 nm and a PDI of approximately 0.3. They had a minor effect on cell viability and caused in a concentration of 0.1 % (m/v) around 10 % hemolysis within 24 h. IAP triggered the cleavage and release of monophosphate from the surface of NLCs causing charge conversion from –22.2 mV to + 5.3 mV (Δ27.5 mV) for PP-linear-CPPs-NLCs and from −19.2 mV to + 11.9 mV (Δ31.1 mV) for PP-loop-CPPs-NLCs. Inhibition of alkaline phosphatase activity on Caco-2 and HEK cells confirmed the involvement of this enzyme in charge conversion. PP-linear-CPPs-NLCs showed on Caco-2 cells a higher uptake than PP-loop-CPPs-NLCs, whereas on HEK cells uptake of both types of NLCs was on the same level. The results of cellular uptake were confirmed visually by confocal microscopy.

Conclusion

CPPs-NLCs coated with polyphosphate are a promising approach to overcome the polycationic dilemma and to enhance cellular uptake.
目的:本研究旨在评估用聚磷酸酯包覆线性和环状细胞穿透肽(CPPs)装饰的纳米结构脂质载体(NLCs)的细胞吸收情况:方法:通过开环聚合合成线性和环状细胞穿透肽(CPPs),并将其固定在纳米脂质载体(NLCs)表面,然后涂上聚磷酸盐(PP)。这些纳米载体(NCs)在粒度、多分散指数(PDI)和ZETA电位方面均有特征。研究了细胞活力、溶血以及游离和膜结合的肠道碱性磷酸酶(IAP)通过磷酸盐裂解诱导的电荷转移。通过流式细胞仪对 Caco-2 和 HEK 细胞的细胞摄取研究进行了定量分析,并用共聚焦显微镜进行了观察:结果:涂覆 PP 后,线型和环型 CPPs-NLC 的电荷均由正向转变为负向。PP-linear-CPPs-NLCs 和 PP-loop-CPPs-NLCs 显示出粒度结论:涂有聚磷酸盐的 CPPs-NLCs 是克服多阳离子困境和提高细胞吸收率的一种可行方法。
{"title":"Nanostructured lipid carriers decorated with polyphosphate coated linear and loop cell-penetrating peptides","authors":"Ahmad Saleh ,&nbsp;Daniel Stengel ,&nbsp;Martyna Truszkowska ,&nbsp;Mariana Blanco Massani ,&nbsp;Gergely Kali ,&nbsp;Andreas Bernkop-Schnürch","doi":"10.1016/j.ijpharm.2024.124844","DOIUrl":"10.1016/j.ijpharm.2024.124844","url":null,"abstract":"<div><h3>Aim</h3><div>This study aimed to evaluate the cellular uptake of nanostructured lipid carriers (NLCs) decorated with polyphosphate coated linear and loop cell-penetrating peptides (CPPs).</div></div><div><h3>Methods</h3><div>Linear-CPPs and loop-CPPs were synthesized via ring-opening polymerization and anchored on the surface NLCs, followed by coating with polyphosphate (PP). These nanocarriers (NCs) were characterized in terms of particle size, polydispersity index (PDI), and zeta potential. Cell viability and hemolysis, as well as enzyme-induced charge conversion via phosphate cleavage by free and membrane-bound intestinal alkaline phosphatase (IAP) were investigated. Cellular uptake studies by Caco-2 and HEK cells were quantitatively analyzed by flow cytometry and visualized by confocal microscopy.</div></div><div><h3>Results</h3><div>A shift in charge from positive to negative was obtained for both linear- and loop-CPPs-NLCs by coating with PP. PP-linear-CPPs-NLCs and PP-loop-CPPs-NLCs exhibited a particle size &lt; 270 nm and a PDI of approximately 0.3. They had a minor effect on cell viability and caused in a concentration of 0.1 % (m/v) around 10 % hemolysis within 24 h. IAP triggered the cleavage and release of monophosphate from the surface of NLCs causing charge conversion from –22.2 mV to + 5.3 mV (Δ27.5 mV) for PP-linear-CPPs-NLCs and from −19.2 mV to + 11.9 mV (Δ31.1 mV) for PP-loop-CPPs-NLCs. Inhibition of alkaline phosphatase activity on Caco-2 and HEK cells confirmed the involvement of this enzyme in charge conversion. PP-linear-CPPs-NLCs showed on Caco-2 cells a higher uptake than PP-loop-CPPs-NLCs, whereas on HEK cells uptake of both types of NLCs was on the same level. The results of cellular uptake were confirmed visually by confocal microscopy.</div></div><div><h3>Conclusion</h3><div>CPPs-NLCs coated with polyphosphate are a promising approach to overcome the polycationic dilemma and to enhance cellular uptake.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"667 ","pages":"Article 124844"},"PeriodicalIF":5.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparation, in vitro and in vivo assessment of novel carvacrol@pro-phytomicelles for the treatment of Salmonella enteritidis infection in mice 用于治疗小鼠肠炎沙门氏菌感染的新型香芹酚@原植物霉素的制备、体外和体内评估。
IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-24 DOI: 10.1016/j.ijpharm.2024.124861
Zhengwei Cui , Mengmeng Zhang , Qingqian Meng , Xianggen Wu , Mengshuang Li
In livestock and poultry farming, the use of antibiotics has been abused, which seriously endangers human health. Thus, antibiotic alternatives are urgently needed. The phytochemical carvacrol (CAR) has attracted attention as an antibiotic alternative due to its excellent antibacterial activity and anti-inflammatory activity. However, CAR has high volatility and low water solubility, which seriously affect its antibacterial activity. In this study, two plant-derived small-molecule phytochemicals—glycyrrhizin and rebaudioside A—were selected as nanocarriers for the preparation of a novel solid pro-phytomicelle formulation named as CAR@PP. Using a simple fabrication method, the encapsulation efficiency of CAR reached 98.74 ± 1.14 %. CAR@PP was found to rapidly dissolve in water, resulting in a transparent solution (named as CAR@M) and a 59-fold increase in solubility compared to CAR. CAR@M contained uniform nanoparticles with a particle size, polydispersity index, and zeta potential of 3.52 ± 0.93 nm, 0.17 ± 0.01, and −10.63 ± 0.45 mV, respectively. The in vitro antibacterial activity of CAR@M was evaluated, and the minimum inhibitory concentration for the tested strains was 125–250 μg/ml. The antibacterial mechanisms were found that CAR@M disrupted the bacterial wall and biomembranes and efficiently inhibited bacterial biofilm growth. To the in vivo activity evaluation, treatment with 50 mg/kg CAR@M could effectively improve bacterial liver abscesses, decrease the inflammatory cytokine levels in the liver and cecum, and reduce the bacterial load in the liver and feces in Salmonella enteritidis-infected mice. In conclusion, CAR@PP is a promising alternative to antibiotics in livestock and poultry farming warranting further research.
在畜禽养殖业中,抗生素的滥用严重危害人类健康。因此,迫切需要抗生素替代品。植物化学物质香芹酚(CAR)因其卓越的抗菌活性和消炎活性,作为抗生素替代品备受关注。然而,香芹酚具有高挥发性和低水溶性,这严重影响了其抗菌活性。本研究选择了两种源自植物的小分子植物化学物质--甘草酸苷和雷公藤甙 A--作为纳米载体,制备了一种名为 CAR@PP 的新型固态原植物胶束制剂。通过简单的制备方法,CAR 的封装效率达到 98.74 ± 1.14 %。研究发现,CAR@PP 能迅速溶解于水,形成透明溶液(命名为 CAR@M),溶解度比 CAR 提高了 59 倍。CAR@M 含有均匀的纳米颗粒,其粒径、多分散指数和 zeta 电位分别为 3.52 ± 0.93 nm、0.17 ± 0.01 和 -10.63 ± 0.45 mV。对 CAR@M 的体外抗菌活性进行了评估,发现其对受试菌株的最小抑菌浓度为 125-250 μg/ml。抗菌机理表明,CAR@M 能破坏细菌壁和生物膜,有效抑制细菌生物膜的生长。在体内活性评价中,50 mg/kg CAR@M 可有效改善细菌性肝脓肿,降低肝脏和盲肠中的炎性细胞因子水平,减少肠炎沙门氏菌感染小鼠肝脏和粪便中的细菌量。总之,CAR@PP 是畜禽养殖中抗生素的一种有前途的替代品,值得进一步研究。
{"title":"Preparation, in vitro and in vivo assessment of novel carvacrol@pro-phytomicelles for the treatment of Salmonella enteritidis infection in mice","authors":"Zhengwei Cui ,&nbsp;Mengmeng Zhang ,&nbsp;Qingqian Meng ,&nbsp;Xianggen Wu ,&nbsp;Mengshuang Li","doi":"10.1016/j.ijpharm.2024.124861","DOIUrl":"10.1016/j.ijpharm.2024.124861","url":null,"abstract":"<div><div>In livestock and poultry farming, the use of antibiotics has been abused, which seriously endangers human health. Thus, antibiotic alternatives are urgently needed. The phytochemical carvacrol (CAR) has attracted attention as an antibiotic alternative due to its excellent antibacterial activity and anti-inflammatory activity. However, CAR has high volatility and low water solubility, which seriously affect its antibacterial activity. In this study, two plant-derived small-molecule phytochemicals—glycyrrhizin and rebaudioside A—were selected as nanocarriers for the preparation of a novel solid pro-phytomicelle formulation named as CAR@PP. Using a simple fabrication method, the encapsulation efficiency of CAR reached 98.74 ± 1.14 %. CAR@PP was found to rapidly dissolve in water, resulting in a transparent solution (named as CAR@M) and a 59-fold increase in solubility compared to CAR. CAR@M contained uniform nanoparticles with a particle size, polydispersity index, and zeta potential of 3.52 ± 0.93 nm, 0.17 ± 0.01, and −10.63 ± 0.45 mV, respectively. The in vitro antibacterial activity of CAR@M was evaluated, and the minimum inhibitory concentration for the tested strains was 125–250 μg/ml. The antibacterial mechanisms were found that CAR@M disrupted the bacterial wall and biomembranes and efficiently inhibited bacterial biofilm growth. To the in vivo activity evaluation, treatment with 50 mg/kg CAR@M could effectively improve bacterial liver abscesses, decrease the inflammatory cytokine levels in the liver and cecum, and reduce the bacterial load in the liver and feces in Salmonella enteritidis-infected mice. In conclusion, CAR@PP is a promising alternative to antibiotics in livestock and poultry farming warranting further research.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"667 ","pages":"Article 124861"},"PeriodicalIF":5.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of high-polarity hydroxyl polyacrylate pressure sensitive adhesive in rizatriptan transdermal drug delivery patch 高极性羟基聚丙烯酸酯压敏胶在利扎曲普坦透皮给药贴片中的应用
IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-24 DOI: 10.1016/j.ijpharm.2024.124862
Cong Li , Donghui Hu , Yafang Xu , Heng Xu , Liang Fang , Guohua Wang , Chao Liu
This study aimed to design a rizatriptan (RIZ) transdermal patch by combining of high-polarity hydroxyl pressure sensitive adhesive (PSA) AAOH-45 with an ion-pair strategy and investigate the molecular mechanism of high content hydroxyl PSA to enhance drug-PSA miscibility. RIZ free base, ion-pair complexes and PSAs containing hydroxyl group were prepared and characterized. Formulation factors including counter-ions, PSAs, drug-loading and others were optimized through single-factor studies and evaluated through pharmacokinetic studies and skin irritation tests. The properties of high polarity PSA and molecular mechanism of drug-PSA miscibility were investigated through molecular simulation, FTIR spectra, 13C NMR spectra, DSC, and rheology study. The optimized formulation contained 20 % (w/w) RIZ-OA (Rizatriptan-Oleic acid), 80 % AAOH-45 (w/w) as the matrix, and had a thickness of 90 μm. Compared with the oral group (MRT0-t = 5.96 ± 0.97 h) and the control patch group (MRT0-t = 11.30 ± 1.78 h), the pharmacokinetic behavior of the optimization group demonstrated sustained drug delivery behavior (MRT0-t = 20.21 ± 0.61 h) with no irritation phenomenon. The miscibility of RIZ with PSAs was positively correlated with the mass percentage of 2-HEA. Higher polar similarity, lower flowability, and stronger intermolecular interaction were responsible for the higher compatibility of high hydroxyl PSA with the drug. This study provided a reference for increasing the drug-loading in PSA and developing RIZ patch.
本研究旨在通过高极性羟基压敏胶(PSA)AAOH-45与离子对策略的结合设计一种利扎曲普坦(RIZ)透皮贴片,并研究高含量羟基压敏胶提高药物与压敏胶相溶性的分子机制。制备并表征了 RIZ 游离基、离子对复合物和含羟基的 PSA。通过单因素研究对包括反离子、PSA、药物负载等在内的配方因素进行了优化,并通过药代动力学研究和皮肤刺激试验进行了评估。通过分子模拟、傅立叶变换红外光谱、13C NMR 光谱、DSC 和流变学研究,考察了高极性 PSA 的性质以及药物与 PSA 相混溶的分子机制。优化后的制剂以 20% 的 RIZ-OA(利扎曲普坦-油酸)和 80% 的 AAOH-45 (重量比)为基质,厚度为 90 μm。与口服组(MRT0-t = 5.96 ± 0.97 h)和对照贴片组(MRT0-t = 11.30 ± 1.78 h)相比,优化组的药代动力学表现为持续给药行为(MRT0-t = 20.21 ± 0.61 h),且无刺激现象。RIZ 与 PSAs 的相溶性与 2-HEA 的质量百分比呈正相关。极性相似度高、流动性低、分子间相互作用强是高羟基 PSA 与药物相容性较高的原因。这项研究为提高 PSA 的药物载量和开发 RIZ 贴片提供了参考。
{"title":"Application of high-polarity hydroxyl polyacrylate pressure sensitive adhesive in rizatriptan transdermal drug delivery patch","authors":"Cong Li ,&nbsp;Donghui Hu ,&nbsp;Yafang Xu ,&nbsp;Heng Xu ,&nbsp;Liang Fang ,&nbsp;Guohua Wang ,&nbsp;Chao Liu","doi":"10.1016/j.ijpharm.2024.124862","DOIUrl":"10.1016/j.ijpharm.2024.124862","url":null,"abstract":"<div><div>This study aimed to design a rizatriptan (RIZ) transdermal patch by combining of high-polarity hydroxyl pressure sensitive adhesive (PSA) AAOH-45 with an ion-pair strategy and investigate the molecular mechanism of high content hydroxyl PSA to enhance drug-PSA miscibility. RIZ free base, ion-pair complexes and PSAs containing hydroxyl group were prepared and characterized. Formulation factors including counter-ions, PSAs, drug-loading and others were optimized through single-factor studies and evaluated through pharmacokinetic studies and skin irritation tests. The properties of high polarity PSA and molecular mechanism of drug-PSA miscibility were investigated through molecular simulation, FTIR spectra, <sup>13</sup>C NMR spectra, DSC, and rheology study. The optimized formulation contained 20 % (<em>w/w</em>) RIZ-OA (Rizatriptan-Oleic acid), 80 % AAOH-45 (<em>w/w</em>) as the matrix, and had a thickness of 90 μm. Compared with the oral group (<em>MRT</em><sub>0-t</sub> = 5.96 ± 0.97 h) and the control patch group (<em>MRT</em><sub>0-t</sub> = 11.30 ± 1.78 h), the pharmacokinetic behavior of the optimization group demonstrated sustained drug delivery behavior (<em>MRT</em><sub>0-t</sub> = 20.21 ± 0.61 h) with no irritation phenomenon. The miscibility of RIZ with PSAs was positively correlated with the mass percentage of 2-HEA. Higher polar similarity, lower flowability, and stronger intermolecular interaction were responsible for the higher compatibility of high hydroxyl PSA with the drug. This study provided a reference for increasing the drug-loading in PSA and developing RIZ patch.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"667 ","pages":"Article 124862"},"PeriodicalIF":5.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A microfluidic in vitro method predicting the fate of peptide drugs after subcutaneous administration 预测皮下注射多肽药物转归的微流体体外方法。
IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-24 DOI: 10.1016/j.ijpharm.2024.124849
Marcus Wanselius , Susanna Abrahmsén-Alami , Belal I. Hanafy , Mariarosa Mazza , Per Hansson
For many biopharmaceuticals, subcutaneous (sc) administration is the only viable route. However, there is no in vitro method available accurately predicting the absorption profiles of subcutaneously injected pharmaceuticals. In this work, we show that a recently developed microfluidics method for interaction studies (MIS) has the potential to be useful in this respect. The method utilises the responsiveness of polyelectrolyte microgel networks to oppositely charged molecules as a means to monitor the interaction between peptides and hyaluronic acid (HA), a major constituent of the subcutaneous extracellular matrix. We use the method to determine parameters describing the strength of interaction between peptide and HA as well as the peptide’s aggregation tendency and transport properties in HA networks. The results from MIS studies of the peptide drugs exenatide, pramlintide, vancomycin, polymyxin B, lanreotide, MEDI7219 and AZD2820 are compared with results from measurements with the commercially available SCISSOR system and in vivo absorption and bioavailability data from the literature. We show that both MIS and SCISSOR reveal differences in the peptides’ diffusivity and tendency to aggregate in the presence of HA. We show that MIS is particularly good at discriminating between peptides forming aggregates stabilised by non-electrostatic forces in the presence of HA, and peptides forming complexes stabilised by electrostatic interactions with HA. The method provides two parameters that can be used to quantify the peptides’ aggregation tendency, the one describing the peptide packing density in complexes with HA and the other the apparent diffusivity upon release in a medium of physiological ionic strength and pH. The order of the peptides when ranked by increasing binding strength at pH 7.4 determined with MIS is shown to be in agreement with the order when ranked by the apparent 1st order absorption rate constant (ka) after sc administration in humans: lanreotide (Autogel) < exenatide (IRF) < AZD2820 < pramlintide < lanreotide (IRF) (IRF: Immediate release formulation). A correlation is found between the 1st order release rate constant determined with SCISSOR and ka for lanreotide (Autogel), exenatide and AZD2820. A mechanism relating the magnitude of ka to the peptides’ charge is proposed.
对于许多生物制药来说,皮下注射是唯一可行的途径。然而,目前还没有一种体外方法能准确预测皮下注射药物的吸收曲线。在这项工作中,我们展示了最近开发的一种用于相互作用研究的微流控方法(MIS)在这方面的应用潜力。该方法利用聚电解质微凝胶网络对带电分子的反应能力,监测肽与透明质酸(HA)(皮下细胞外基质的主要成分)之间的相互作用。我们用这种方法来确定描述肽与透明质酸之间相互作用强度的参数,以及肽在透明质酸网络中的聚集趋势和传输特性。我们将多肽药物艾塞那肽、普拉克林肽、万古霉素、多粘菌素 B、兰瑞奥肽、MEDI7219 和 AZD2820 的 MIS 研究结果与市售 SCISSOR 系统的测量结果以及文献中的体内吸收和生物利用度数据进行了比较。我们发现,MIS 和 SCISSOR 都能揭示肽在有 HA 存在时的扩散性和聚集倾向的差异。我们的研究表明,MIS 尤其擅长区分在 HA 存在下由非静电力稳定形成聚集体的多肽和由与 HA 的静电相互作用稳定形成复合物的多肽。该方法提供了两个可用于量化多肽聚集趋势的参数,一个是描述多肽在与 HA 的复合物中的堆积密度,另一个是在生理离子强度和 pH 值介质中释放时的表观扩散性。用 MIS 测定的多肽在 pH 值为 7.4 时按结合强度递增排序的顺序与在人体 sc 给药后按表观一阶吸收速率常数 (ka) 排序的顺序一致:兰瑞奥肽(Autogel)a、艾塞那肽和 AZD2820。提出了 ka 大小与肽电荷相关的机制。
{"title":"A microfluidic in vitro method predicting the fate of peptide drugs after subcutaneous administration","authors":"Marcus Wanselius ,&nbsp;Susanna Abrahmsén-Alami ,&nbsp;Belal I. Hanafy ,&nbsp;Mariarosa Mazza ,&nbsp;Per Hansson","doi":"10.1016/j.ijpharm.2024.124849","DOIUrl":"10.1016/j.ijpharm.2024.124849","url":null,"abstract":"<div><div>For many biopharmaceuticals, subcutaneous (sc) administration is the only viable route. However, there is no <em>in vitro</em> method available accurately predicting the absorption profiles of subcutaneously injected pharmaceuticals. In this work, we show that a recently developed microfluidics method for interaction studies (MIS) has the potential to be useful in this respect. The method utilises the responsiveness of polyelectrolyte microgel networks to oppositely charged molecules as a means to monitor the interaction between peptides and hyaluronic acid (HA), a major constituent of the subcutaneous extracellular matrix. We use the method to determine parameters describing the strength of interaction between peptide and HA as well as the peptide’s aggregation tendency and transport properties in HA networks. The results from MIS studies of the peptide drugs exenatide, pramlintide, vancomycin, polymyxin B, lanreotide, MEDI7219 and AZD2820 are compared with results from measurements with the commercially available SCISSOR system and <em>in vivo</em> absorption and bioavailability data from the literature. We show that both MIS and SCISSOR reveal differences in the peptides’ diffusivity and tendency to aggregate in the presence of HA. We show that MIS is particularly good at discriminating between peptides forming aggregates stabilised by non-electrostatic forces in the presence of HA, and peptides forming complexes stabilised by electrostatic interactions with HA. The method provides two parameters that can be used to quantify the peptides’ aggregation tendency, the one describing the peptide packing density in complexes with HA and the other the apparent diffusivity upon release in a medium of physiological ionic strength and pH. The order of the peptides when ranked by increasing binding strength at pH 7.4 determined with MIS is shown to be in agreement with the order when ranked by the apparent 1st order absorption rate constant (<em>k<sub>a</sub></em>) after sc administration in humans: lanreotide (Autogel) &lt; exenatide (IRF) &lt; AZD2820 &lt; pramlintide &lt; lanreotide (IRF) (IRF: Immediate release formulation). A correlation is found between the 1st order release rate constant determined with SCISSOR and <em>k<sub>a</sub></em> for lanreotide (Autogel), exenatide and AZD2820. A mechanism relating the magnitude of <em>k<sub>a</sub></em> to the peptides’ charge is proposed.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"667 ","pages":"Article 124849"},"PeriodicalIF":5.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Pharmaceutics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1